US BANCORP \DE\ - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,661
-15.7%
428
-31.2%
0.00%
Q2 2023$13,840
+23.4%
622
+20.1%
0.00%
Q1 2023$11,220
+83.5%
518
+72.1%
0.00%
Q4 2022$6,114
+1.9%
301
+25.9%
0.00%
Q3 2022$6,000
+200.0%
239
+121.3%
0.00%
Q2 2022$2,000
+100.0%
108
+56.5%
0.00%
Q1 2022$1,000
-50.0%
69
-14.8%
0.00%
Q1 2021$2,000
-33.3%
81
-52.9%
0.00%
Q3 2020$3,000
-50.0%
172
-51.0%
0.00%
Q2 2020$6,000
+200.0%
351
+96.1%
0.00%
Q1 2020$2,0000.0%1790.0%0.00%
Q4 2019$2,000
-33.3%
1790.0%0.00%
Q3 2019$3,000
+50.0%
1790.0%0.00%
Q2 2019$2,000
-33.3%
179
-4.8%
0.00%
Q4 2018$3,000
+200.0%
188
+111.2%
0.00%
Q3 2018$1,000
-98.7%
89
-98.1%
0.00%
Q1 2018$76,000
-35.0%
4,648
-28.5%
0.00%
Q4 2017$117,000
-4.9%
6,499
+2.2%
0.00%
Q3 2017$123,000
+515.0%
6,357
+272.0%
0.00%
Q2 2017$20,0001,7090.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,825,262$138,6217.54%
Novo Holdings A/S 3,377,768$68,602,4684.28%
Parallel Advisors, LLC 3,724,664$75,647,9263.28%
TANAKA CAPITAL MANAGEMENT INC 35,539$7222.29%
Quantedge Capital Pte Ltd 251,312$5,104,1471.71%
S&T BANK/PA 346,306$7,0331.30%
Freshford Capital Management, LLC 249,000$5,057,1901.09%
Birchview Capital, LP 50,000$1,0160.72%
FAS Wealth Partners, Inc. 306,276$6,220,4660.70%
Bridge City Capital, LLC 60,824$1,2350.63%
View complete list of CORCEPT THERAPEUTICS INC shareholders